Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022 - Product Thumbnail Image

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

  • Report
  • 70 Pages
From
Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations - Product Thumbnail Image

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • Report
  • 63 Pages
From
Papillary Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Papillary Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 72 Pages
From
Medullary Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Medullary Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 88 Pages
From
Follicular Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Follicular Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 62 Pages
From
Thyroid Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2018

  • Report
  • 567 Pages
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2018 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Papillary Thyroid Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Review, H1 2016

  • Report
  • 106 Pages
From
Follicular Thyroid Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Follicular Thyroid Cancer - Pipeline Review, H1 2016

  • Report
  • 83 Pages
From
Anaplastic Thyroid Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Review, H1 2016

  • Report
  • 85 Pages
From
Papillary Thyroid Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Review, H2 2015

  • Report
  • 115 Pages
From
Anaplastic Thyroid Cancer - Pipeline Review, H1 2015 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Review, H1 2015

  • Report
  • 82 Pages
From
Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Merkel Cell Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Review, H2 2017

  • Report
  • 346 Pages
From
Wilms' Tumor (Nephroblastoma) - Pipeline Review, H2 2016 - Product Thumbnail Image

Wilms' Tumor (Nephroblastoma) - Pipeline Review, H2 2016

  • Report
  • 54 Pages
From
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015 - Product Thumbnail Image

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

  • Report
  • 168 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Pheochromocytoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H1 2018

  • Report
  • 99 Pages
From
Market Spotlight: Thyroid Cancer - Product Thumbnail Image

Market Spotlight: Thyroid Cancer

  • Report
  • 36 Pages
From
Loading Indicator
adroll